Anders Rosengren
21 – 30 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Can genetics improve precision of therapy in diabetes?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist.
(
- Contribution to journal › Article
- 2013
-
Mark
Eukaryotic translation initiation factor 3 subunit e controls intracellular calcium homeostasis by regulation of cav1.2 surface expression.
(
- Contribution to journal › Article
- 2012
-
Mark
Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Reduced Insulin Exocytosis in Human Pancreatic β-cells With Gene Variants Linked to Type 2 Diabetes.
(
- Contribution to journal › Article
-
Mark
A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets.
(
- Contribution to journal › Article
- 2010
-
Mark
The role of wnt antagonists in impaired beta cell exocytosis
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.91-91(
- Contribution to journal › Published meeting abstract
-
Mark
GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis.
(
- Contribution to journal › Article
-
Mark
Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes.
(
- Contribution to journal › Article
- 2009
-
Mark
Hyperactivity in adrenergic signalling via alpha2A receptors contributes to human type 2 diabetes
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.108-108(
- Contribution to journal › Published meeting abstract